Medtronic plc (MDT) Stock Score, Valuation & Financial Research
Medtronic plc is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 36/100.
Quick answer for MDT
Medtronic plc currently has a Wall Street Score of 36/100. The stored market price is $92.6. Its financial score is 29/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What Medtronic plc does
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical
MDT financial snapshot
- Wall Street Score:
- 36/100
- Current price:
- $92.6
- Market capitalization:
- $118.53B
- Revenue:
- $36.36B
- Net income:
- $4.80B
- Free cash flow:
- $5.43B
- Cash:
- $1.95B
- Total debt:
- $27.96B
- EPS:
- 3.75
- P/E ratio:
- 24.7x
- Financial score:
- 29/100
- Valuation score:
- 16/100
- Revenue score:
- 18/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $5.43B, showing positive cash generation.
- The balance sheet shows $1.95B of cash versus $27.96B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MDT
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.